Positive Interim Data of BellaSeno's Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023 Data presented at RACS 91st Annual Scientific Congress 2023Initial findings demonstrate that BellaSeno’s resorbable implants are safe, well tolerated and lead to natural tissue growth Leipzig,...

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants Expanded partnership of two leading innovatorsResomer® used in commercial 3D-printed implants for both soft and hard tissue applicationsBellaSeno receives market authorization for fully resorbable...